Selected research
Industry Research
Cell Culture Service Industry Research Report 2026
Market perspective
The global Cell Culture Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell Culture Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell Culture Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell Culture Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell Culture Service include Danaher, Lonza, WuXi Biologics, Samsung Biologics, Charles River Laboratories, Labcorp Drug Development, Eurofins Scientific, Evotec and Catalent, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell Culture Service market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Culture Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Culture Service Market by Company
Danaher
Lonza
WuXi Biologics
Samsung Biologics
Charles River Laboratories
Labcorp Drug Development
Eurofins Scientific
Evotec
Catalent
AGC Biologics
ProBioGen
Pharmaron
Takara Bio
AGC Biologics Japan
Thermo Fisher Scientific
Merck KGaA
Sartorius
Cell Culture Service Segment by Type
Primary Cells
Transformed Cells
Self-renewing Cells
Cell Culture Service Segment by Application
Research Institute
Hospital
Others
Cell Culture Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Culture Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Culture Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Culture Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Culture Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Primary Cells
- Transformed Cells
- Self-renewing Cells
Applications
- Research Institute
- Hospital
- Others
Companies covered
- Danaher
- Lonza
- WuXi Biologics
- Samsung Biologics
- Charles River Laboratories
- Labcorp Drug Development
- Eurofins Scientific
- Evotec
- Catalent
- AGC Biologics
- ProBioGen
- Pharmaron
- Takara Bio
- AGC Biologics Japan
- Thermo Fisher Scientific
- Merck KGaA
- Sartorius
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Culture Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Primary Cells
- 2.2.3 Transformed Cells
- 2.2.4 Self-renewing Cells
- 2.3 Cell Culture Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Research Institute
- 2.3.3 Hospital
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Cell Culture Service Breakdown Data by Type
- 3.1 Global Cell Culture Service Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Culture Service Forecasted Market Size by Type (2027-2032)
4 Cell Culture Service Breakdown Data by Application
- 4.1 Global Cell Culture Service Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Culture Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Culture Service Market Perspective (2021-2032)
- 5.2 Global Cell Culture Service Growth Trends by Region
- 5.2.1 Global Cell Culture Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Culture Service Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Culture Service Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Culture Service Market Dynamics
- 5.3.1 Cell Culture Service Industry Trends
- 5.3.2 Cell Culture Service Market Drivers
- 5.3.3 Cell Culture Service Market Challenges
- 5.3.4 Cell Culture Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Culture Service Players by Revenue
- 6.1.1 Global Top Cell Culture Service Players by Revenue (2021-2026)
- 6.1.2 Global Cell Culture Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Culture Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Culture Service Head Office and Area Served
- 6.4 Global Cell Culture Service Players, Product Type & Application
- 6.5 Global Cell Culture Service Manufacturers Established Date
- 6.6 Global Cell Culture Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Culture Service Market Size (2021-2032)
- 7.2 North America Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Culture Service Market Size by Country (2021-2026)
- 7.4 North America Cell Culture Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Culture Service Market Size (2021-2032)
- 8.2 Europe Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Culture Service Market Size by Country (2021-2026)
- 8.4 Europe Cell Culture Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Culture Service Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Culture Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Culture Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Culture Service Market Size (2021-2032)
- 10.2 South America Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Culture Service Market Size by Country (2021-2026)
- 10.4 South America Cell Culture Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Culture Service Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Culture Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Culture Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Culture Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Danaher
- 12.1.1 Danaher Company Information
- 12.1.2 Danaher Business Overview
- 12.1.3 Danaher Revenue in Cell Culture Service Business (2021-2026)
- 12.1.4 Danaher Cell Culture Service Product Portfolio
- 12.1.5 Danaher Recent Developments
- 12.2 Lonza
- 12.2.1 Lonza Company Information
- 12.2.2 Lonza Business Overview
- 12.2.3 Lonza Revenue in Cell Culture Service Business (2021-2026)
- 12.2.4 Lonza Cell Culture Service Product Portfolio
- 12.2.5 Lonza Recent Developments
- 12.3 WuXi Biologics
- 12.3.1 WuXi Biologics Company Information
- 12.3.2 WuXi Biologics Business Overview
- 12.3.3 WuXi Biologics Revenue in Cell Culture Service Business (2021-2026)
- 12.3.4 WuXi Biologics Cell Culture Service Product Portfolio
- 12.3.5 WuXi Biologics Recent Developments
- 12.4 Samsung Biologics
- 12.4.1 Samsung Biologics Company Information
- 12.4.2 Samsung Biologics Business Overview
- 12.4.3 Samsung Biologics Revenue in Cell Culture Service Business (2021-2026)
- 12.4.4 Samsung Biologics Cell Culture Service Product Portfolio
- 12.4.5 Samsung Biologics Recent Developments
- 12.5 Charles River Laboratories
- 12.5.1 Charles River Laboratories Company Information
- 12.5.2 Charles River Laboratories Business Overview
- 12.5.3 Charles River Laboratories Revenue in Cell Culture Service Business (2021-2026)
- 12.5.4 Charles River Laboratories Cell Culture Service Product Portfolio
- 12.5.5 Charles River Laboratories Recent Developments
- 12.6 Labcorp Drug Development
- 12.6.1 Labcorp Drug Development Company Information
- 12.6.2 Labcorp Drug Development Business Overview
- 12.6.3 Labcorp Drug Development Revenue in Cell Culture Service Business (2021-2026)
- 12.6.4 Labcorp Drug Development Cell Culture Service Product Portfolio
- 12.6.5 Labcorp Drug Development Recent Developments
- 12.7 Eurofins Scientific
- 12.7.1 Eurofins Scientific Company Information
- 12.7.2 Eurofins Scientific Business Overview
- 12.7.3 Eurofins Scientific Revenue in Cell Culture Service Business (2021-2026)
- 12.7.4 Eurofins Scientific Cell Culture Service Product Portfolio
- 12.7.5 Eurofins Scientific Recent Developments
- 12.8 Evotec
- 12.8.1 Evotec Company Information
- 12.8.2 Evotec Business Overview
- 12.8.3 Evotec Revenue in Cell Culture Service Business (2021-2026)
- 12.8.4 Evotec Cell Culture Service Product Portfolio
- 12.8.5 Evotec Recent Developments
- 12.9 Catalent
- 12.9.1 Catalent Company Information
- 12.9.2 Catalent Business Overview
- 12.9.3 Catalent Revenue in Cell Culture Service Business (2021-2026)
- 12.9.4 Catalent Cell Culture Service Product Portfolio
- 12.9.5 Catalent Recent Developments
- 12.10 AGC Biologics
- 12.10.1 AGC Biologics Company Information
- 12.10.2 AGC Biologics Business Overview
- 12.10.3 AGC Biologics Revenue in Cell Culture Service Business (2021-2026)
- 12.10.4 AGC Biologics Cell Culture Service Product Portfolio
- 12.10.5 AGC Biologics Recent Developments
- 12.11 ProBioGen
- 12.11.1 ProBioGen Company Information
- 12.11.2 ProBioGen Business Overview
- 12.11.3 ProBioGen Revenue in Cell Culture Service Business (2021-2026)
- 12.11.4 ProBioGen Cell Culture Service Product Portfolio
- 12.11.5 ProBioGen Recent Developments
- 12.12 Pharmaron
- 12.12.1 Pharmaron Company Information
- 12.12.2 Pharmaron Business Overview
- 12.12.3 Pharmaron Revenue in Cell Culture Service Business (2021-2026)
- 12.12.4 Pharmaron Cell Culture Service Product Portfolio
- 12.12.5 Pharmaron Recent Developments
- 12.13 Takara Bio
- 12.13.1 Takara Bio Company Information
- 12.13.2 Takara Bio Business Overview
- 12.13.3 Takara Bio Revenue in Cell Culture Service Business (2021-2026)
- 12.13.4 Takara Bio Cell Culture Service Product Portfolio
- 12.13.5 Takara Bio Recent Developments
- 12.14 AGC Biologics Japan
- 12.14.1 AGC Biologics Japan Company Information
- 12.14.2 AGC Biologics Japan Business Overview
- 12.14.3 AGC Biologics Japan Revenue in Cell Culture Service Business (2021-2026)
- 12.14.4 AGC Biologics Japan Cell Culture Service Product Portfolio
- 12.14.5 AGC Biologics Japan Recent Developments
- 12.15 Thermo Fisher Scientific
- 12.15.1 Thermo Fisher Scientific Company Information
- 12.15.2 Thermo Fisher Scientific Business Overview
- 12.15.3 Thermo Fisher Scientific Revenue in Cell Culture Service Business (2021-2026)
- 12.15.4 Thermo Fisher Scientific Cell Culture Service Product Portfolio
- 12.15.5 Thermo Fisher Scientific Recent Developments
- 12.16 Merck KGaA
- 12.16.1 Merck KGaA Company Information
- 12.16.2 Merck KGaA Business Overview
- 12.16.3 Merck KGaA Revenue in Cell Culture Service Business (2021-2026)
- 12.16.4 Merck KGaA Cell Culture Service Product Portfolio
- 12.16.5 Merck KGaA Recent Developments
- 12.17 Sartorius
- 12.17.1 Sartorius Company Information
- 12.17.2 Sartorius Business Overview
- 12.17.3 Sartorius Revenue in Cell Culture Service Business (2021-2026)
- 12.17.4 Sartorius Cell Culture Service Product Portfolio
- 12.17.5 Sartorius Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst